Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000937
Chunk: 24

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 24
---
, amend or affect the Investor’s right to rely on the Company’s representations
and warranties contained in below. The Investor has sought such accounting, legal and tax advice from its own independent
advisors as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities and
is not relying on any accounting, legal, tax or other advice from the Company or its officers, employees or representatives. The Investor
acknowledges and agrees that the Company neither makes nor has made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in hereof.

(f) . The Investor understands that no U.S. federal or state agency or any other government or governmental agency
has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of an investment in the Securities
nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

| -11- |

(g) . The Investor understands that (i) the Securities may not be offered for sale, sold, assigned or transferred unless (A) registered
pursuant to the Securities Act or (B) an exemption exists permitting such Securities to be sold, assigned or transferred without such
registration; (ii) any sale of the Securities made in reliance on Rule 144 may be made only in accordance with the terms of Rule 144 and
further, if Rule 144 is not applicable, any resale of the Securities under circumstances in which the seller (or the Person through whom
the sale is made) may be deemed to be an underwriter (as that term is defined in the Securities Act) may require compliance with some
other exemption under the Securities Act or the rules and regulations of the SEC thereunder.

(h) . This Agreement and the Registration Rights Agreement have been duly and validly authorized, executed and delivered on
behalf of the Investor and is a valid and binding agreement of the Investor enforceable against the Investor in accordance with its terms,
subject as to enforceability to general principles of equity and to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
and other laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

(i) .
The Investor’s primary place of business is in the State of Florida.

(j) . The Investor represents and warrants to the Company that at no time prior to the date of this Agreement has any of
the Investor, its agents, representatives or affiliates engaged in or effected